Koers Targeted Medical Pharma, Inc. Other OTC
Aandelen
TRGM
US8761401046
Farmaceutische producten
Omzet 2014 | 7,11 mln. 6,61 mln. | Omzet 2015 | 5,26 mln. 4,89 mln. | Marktkapitalisatie | 429K 399K |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -3 mln. -2,79 mln. | Nettowinst (verlies) 2015 | -3 mln. -2,79 mln. | EV/omzet 2014 | 1,28 x |
Nettoschuld 2014 | 3,71 mln. 3,45 mln. | Nettoschuld 2015 | 5,21 mln. 4,84 mln. | EV/omzet 2015 | 1,07 x |
K/w-verhouding 2014 |
-1,37
x | K/w-verhouding 2015 |
-0,14
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 38,35% |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 84 | 01-02-11 | |
Director/Board Member | 80 | 04-03-14 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,98% | 43,48 mld. | |
+20,67% | 22,65 mld. | |
+14,56% | 14,73 mld. | |
+14,32% | 13,79 mld. | |
+44,72% | 12,04 mld. | |
-8,37% | 7,08 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+11,90% | 5,47 mld. |